Neuronetics has closed $30 million of Series E financing. The deal was led by two new investors, Polaris Venture Partners and Pfizer Venture Investments.

Investors participating in the previous round of financing included Investor Growth Capital, New Leaf Venture Partners and Interwest Partners. The firm is a maker of the NeuroStar TMS Therapy System.

Click here for the release from Market Wire.